VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
3211
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
578
Interactions with Platform & by Email
PARTICIPANTS
96
Unique # Participated
VALIDATIONS
43
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
105
PAGES
181
EDITION
8
PRICE
USD $4950
Focus On Cell-Based Products, One of the Largest Segments in the Brain Tumor Therapeutics Market.
Will this Market be a Huge Opportunity by 2025?
Amid the COVID-19 crisis, the global market for Brain Tumor Therapeutics estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at aCAGR of 9.6% over the period 2020-2027. Cell-Based Products, one of the segments analyzed in the report, is projected to record 10.1% CAGR and reach US$2.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Acellular Products segment is readjusted to a revised 8.6% CAGR for the next 7-year period.
The Brain Tumor Therapeutics market in the U.S. is estimated at US$519.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$575.2 Million by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.We bring years of research experience to this 8th edition of our report. The 181-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
AstraZeneca PLC; Bristol-Myers Squibb Company; DelMar Pharmaceuticals, Inc.; Eisai Co., Ltd.; Emcure Pharmaceuticals Pvt., Ltd.; F. Hoffmann-La Roche AG; Fresenius Kabi Oncology Ltd.; ImmunoCellular Therapeutics Ltd.; iTeos Therapeutics SA; Kazia Therapeutics Ltd.; Merck & Co., Inc.; Moleculin Biotech, Inc.; Navinta LLC; NextSource Biotechnology, LLC; Northwest Biotherapeutics, Inc.; Novartis International AG; NovoCure Ltd. (Channel Islands); Tocagen, Inc.; United Technologies Corporation (UTC)
» Product (Cell-Based Products, Acellular Products) » Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Brain Tumor Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Brain Tumor Therapeutics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Brain Tumor Therapeutics Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 |
| Brain Tumor Therapeutics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Cell-Based Products (Product) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| Cell-Based Products (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 |
| Cell-Based Products (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Acellular Products (Product) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 |
| Acellular Products (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019 |
| Acellular Products (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Cell Therapy (Therapy) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 |
| Cell Therapy (Therapy) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019 |
| Cell Therapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Tissue Engineering (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027 |
| Tissue Engineering (Therapy) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019 |
| Tissue Engineering (Therapy) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Immunotherapy (Therapy) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| Immunotherapy (Therapy) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 |
| Immunotherapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Gene Therapy (Therapy) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027 |
| Gene Therapy (Therapy) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2012 to 2019 |
| Gene Therapy (Therapy) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Brain Tumor Therapeutics Market Share (in %) by Company: 2019 & 2025 |
| United States Brain Tumor Therapeutics Market Estimates and Projections in US$ Thousand by Product: 2020 to 2027 |
| Brain Tumor Therapeutics Market in the United States by Product: A Historic Review in US$ Thousand for 2012-2019 |
| United States Brain Tumor Therapeutics Market Share Breakdown by Product: 2012 VS 2020 VS 2027 |
| United States Brain Tumor Therapeutics Market Estimates and Projections in US$ Thousand by Therapy: 2020 to 2027 |
| Brain Tumor Therapeutics Market in the United States by Therapy: A Historic Review in US$ Thousand for 2012-2019 |
| United States Brain Tumor Therapeutics Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027 |
| CANADA |
| Canadian Brain Tumor Therapeutics Market Estimates and Forecasts in US$ Thousand by Product: 2020 to 2027 |
| Canadian Brain Tumor Therapeutics Historic Market Review by Product in US$ Thousand: 2012-2019 |
| Brain Tumor Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027 |
| Canadian Brain Tumor Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2020 to 2027 |
| Canadian Brain Tumor Therapeutics Historic Market Review by Therapy in US$ Thousand: 2012-2019 |
| Brain Tumor Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2012, 2020, and 2027 |
| JAPAN |
| Japanese Market for Brain Tumor Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2020-2027 |
| Brain Tumor Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2012-2019 |
| Japanese Brain Tumor Therapeutics Market Share Analysis by Product: 2012 VS 2020 VS 2027 |
| Japanese Market for Brain Tumor Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2020-2027 |
| Brain Tumor Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2012-2019 |
| Japanese Brain Tumor Therapeutics Market Share Analysis by Therapy: 2012 VS 2020 VS 2027 |
| CHINA |
| Chinese Brain Tumor Therapeutics Market Growth Prospects in US$ Thousand by Product for the Period 2020-2027 |
| Brain Tumor Therapeutics Historic Market Analysis in China in US$ Thousand by Product: 2012-2019 |
| Chinese Brain Tumor Therapeutics Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Brain Tumor Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2020-2027 |
| Brain Tumor Therapeutics Historic Market Analysis in China in US$ Thousand by Therapy: 2012-2019 |
| Chinese Brain Tumor Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| EUROPE |
| Market Facts & Figures |
| European Brain Tumor Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Brain Tumor Therapeutics Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 |
| Brain Tumor Therapeutics Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 |
| European Brain Tumor Therapeutics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Brain Tumor Therapeutics Market Estimates and Forecasts in US$ Thousand by Product: 2020-2027 |
| Brain Tumor Therapeutics Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2012-2019 |
| European Brain Tumor Therapeutics Market Share Breakdown by Product: 2012 VS 2020 VS 2027 |
| European Brain Tumor Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2020-2027 |
| Brain Tumor Therapeutics Market in Europe in US$ Thousand by Therapy: A Historic Review for the Period 2012-2019 |
| European Brain Tumor Therapeutics Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027 |
| FRANCE |
| Brain Tumor Therapeutics Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| French Brain Tumor Therapeutics Historic Market Scenario in US$ Thousand by Product: 2012-2019 |
| French Brain Tumor Therapeutics Market Share Analysis by Product: 2012 VS 2020 VS 2027 |
| Brain Tumor Therapeutics Market in France by Therapy: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| French Brain Tumor Therapeutics Historic Market Scenario in US$ Thousand by Therapy: 2012-2019 |
| French Brain Tumor Therapeutics Market Share Analysis by Therapy: 2012 VS 2020 VS 2027 |
| GERMANY |
| Brain Tumor Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2020-2027 |
| German Brain Tumor Therapeutics Historic Market Analysis in US$ Thousand by Product: 2012-2019 |
| German Brain Tumor Therapeutics Market Share Breakdown by Product: 2012 VS 2020 VS 2027 |
| Brain Tumor Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Therapy for the Period 2020-2027 |
| German Brain Tumor Therapeutics Historic Market Analysis in US$ Thousand by Therapy: 2012-2019 |
| German Brain Tumor Therapeutics Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027 |
| ITALY |
| Italian Brain Tumor Therapeutics Market Growth Prospects in US$ Thousand by Product for the Period 2020-2027 |
| Brain Tumor Therapeutics Historic Market Analysis in Italy in US$ Thousand by Product: 2012-2019 |
| Italian Brain Tumor Therapeutics Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Brain Tumor Therapeutics Market Growth Prospects in US$ Thousand by Therapy for the Period 2020-2027 |
| Brain Tumor Therapeutics Historic Market Analysis in Italy in US$ Thousand by Therapy: 2012-2019 |
| Italian Brain Tumor Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Brain Tumor Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2020-2027 |
| Brain Tumor Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2012-2019 |
| United Kingdom Brain Tumor Therapeutics Market Share Analysis by Product: 2012 VS 2020 VS 2027 |
| United Kingdom Market for Brain Tumor Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Therapy for the Period 2020-2027 |
| Brain Tumor Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Therapy for the Period 2012-2019 |
| United Kingdom Brain Tumor Therapeutics Market Share Analysis by Therapy: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Brain Tumor Therapeutics Market Estimates and Forecasts in US$ Thousand by Product: 2020-2027 |
| Brain Tumor Therapeutics Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2012-2019 |
| Rest of Europe Brain Tumor Therapeutics Market Share Breakdown by Product: 2012 VS 2020 VS 2027 |
| Rest of Europe Brain Tumor Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2020-2027 |
| Brain Tumor Therapeutics Market in Rest of Europe in US$ Thousand by Therapy: A Historic Review for the Period 2012-2019 |
| Rest of Europe Brain Tumor Therapeutics Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Brain Tumor Therapeutics Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| Asia-Pacific Brain Tumor Therapeutics Historic Market Scenario in US$ Thousand by Product: 2012-2019 |
| Asia-Pacific Brain Tumor Therapeutics Market Share Analysis by Product: 2012 VS 2020 VS 2027 |
| Brain Tumor Therapeutics Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| Asia-Pacific Brain Tumor Therapeutics Historic Market Scenario in US$ Thousand by Therapy: 2012-2019 |
| Asia-Pacific Brain Tumor Therapeutics Market Share Analysis by Therapy: 2012 VS 2020 VS 2027 |
| REST OF WORLD |
| Rest of World Brain Tumor Therapeutics Market Estimates and Forecasts in US$ Thousand by Product: 2020 to 2027 |
| Rest of World Brain Tumor Therapeutics Historic Market Review by Product in US$ Thousand: 2012-2019 |
| Brain Tumor Therapeutics Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027 |
| Rest of World Brain Tumor Therapeutics Market Estimates and Forecasts in US$ Thousand by Therapy: 2020 to 2027 |
| Rest of World Brain Tumor Therapeutics Historic Market Review by Therapy in US$ Thousand: 2012-2019 |
| Brain Tumor Therapeutics Market in Rest of World: Percentage Share Breakdown of Sales by Therapy for 2012, 2020, and 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 18 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com